An Overview of the Effects of Lithium on Alzheimer’s Disease: A Historical Perspective
Pharmaceuticals · 05.04.2025 · 18 (4) · 532
DOI: 10.3390/ph18040532 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 05.04.2025. Verfasst von Marcia Radanovic und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neuroscience (LIM-27), Department and Institute of Psychiatry, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Pa…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: São Paulo Research Foundation, Programa Nacional de Apoio à Atenção da Saúde da Pessoa com Deficiência, Instituto Nacional de Biomarcadores em Neuropsiquiatria.
Themen: Demenz
Abstract (Originalsprache)
Lithium was introduced into psychiatric practice in the late nineteenth century and has since become a standard treatment for severe psychiatric disorders, particularly those characterized by psychotic agitation. It remains the most effective agent for managing acute mania and preventing relapses in bipolar disorder. Despite potential adverse effects, lithium’s use should be carefully considered relative to other treatment options, as these alternatives may present distinct safety and tolerability profiles. The World Health Organization classifies lithium salts as ‘essential’ medications for inclusion in global healthcare systems. Over the past two decades, the growing recognition of lithium’s efficacy—extending beyond mood stabilization to include reducing suicide risk and inducing neuroprotection—has led to its incorporation into clinical practice guidelines. Current research, particularly from translational models, suggests that lithium’s pleiotropic effects benefit not only mental and brain health but also other organs and systems. This supports its potential as a therapeutic candidate for neurological conditions, particularly those associated with neurodegenerative processes. This article will discuss the historical background, discovery, and early experimentation of lithium in psychiatry. We will also review its mechanisms of action and discuss its potential in the treatment and prevention of neurodegenerative disorders, focusing on Alzheimer’s disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Neuroscience (LIM-27), Department and Institute of Psychiatry, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo 05403-010, SP, Brazil.
- Instituto Nacional de Biomarcadores em Neuropsiquiatria (INBioN), Conselho Nacional de Desenvolvimento Científico e Tecnológico, São Paulo 05403-010, SP, Brazil.
- Centro de Neurociências Translacionais (CNT), Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo 05403-010, SP, Brazil.
ORCID-Profile: Marcia Radanovic, Monique Patricio Singulani, Vanessa de Jesus R De Paula, Leda Leme Talib, Orestes Vicente Forlenza
Förderung
- São Paulo Research Foundation
- Programa Nacional de Apoio à Atenção da Saúde da Pessoa com Deficiência
- Instituto Nacional de Biomarcadores em Neuropsiquiatria
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Radanovic, M., Singulani, M. P., De Paula, V. J. R., Talib, L. L., & Forlenza, O. V. (2025). An Overview of the Effects of Lithium on Alzheimer’s Disease: A Historical Perspective. Pharmaceuticals, 18(4), 532. https://doi.org/10.3390/ph18040532
Vancouver
Radanovic M, Singulani MP, De Paula VJR, Talib LL, Forlenza OV. An Overview of the Effects of Lithium on Alzheimer’s Disease: A Historical Perspective. Pharmaceuticals. 2025;18(4):532. doi:10.3390/ph18040532
BibTeX
@article{Radanovic2025,
author = {Radanovic, Marcia and Singulani, Monique Patricio and De Paula, Vanessa de Jesus R and Talib, Leda Leme and Forlenza, Orestes Vicente},
title = {An Overview of the Effects of Lithium on Alzheimer’s Disease: A Historical Perspective},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {4},
pages = {532},
doi = {10.3390/ph18040532}
}
EUVIMED